Literature DB >> 16838140

Evidence for association of SLC7A9 gene haplotypes with cystinuria manifestation in SLC7A9 mutation carriers.

Anthoula Chatzikyriakidou1, Nikolaos Sofikitis, Vasiliki Kalfakakou, Konstantinos Siamopoulos, Ioannis Georgiou.   

Abstract

Cystinuria is a complex genetic disorder. In the present study, we report on the strict linkage disequilibrium of SLC7A9 mutations with the wild type SLC7A9 haplotype of 15 single nucleotide polymorphisms (SNPs) and their effect on cystinuria manifestation and classification. Specifically, screening for mutations and polymorphisms was performed in the family members of ten cystinuric patients with SLC7A9 gene mutations. The molecular genetic and clinical data of cystinuric patients and their relatives were combined to construct the SLC7A9 SNP haplotypes and evaluate the manifestation of the disorder in carriers for a SLC7A9 gene mutation. It was found that all carriers of a SLC7A9 mutation manifested cystinuria if their normal allele had non-wild type nucleotides in two or more of the identified polymorphic sites. Subsequently, the polymorphic background of the SLC7A9 gene probably affects the expression of the disorder in SLC7A9 mutation carriers and points to a revised genetic classification of cystinuric patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838140     DOI: 10.1007/s00240-006-0060-6

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  17 in total

Review 1.  Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.

Authors:  R L Nagel; M H Steinberg
Journal:  Pediatr Pathol Mol Med       Date:  2001 Mar-Apr

2.  Genomic and functional investigations of mutations of the SLC3A1 gene in cystinuria.

Authors:  Sven Lahme; Karl-Horst Bichler; Thomas Eggermann; Florian Lang
Journal:  Urol Int       Date:  2002       Impact factor: 2.089

3.  A survey of genetic and epigenetic variation affecting human gene expression.

Authors:  Tomi Pastinen; Robert Sladek; Scott Gurd; Alya'a Sammak; Bing Ge; Pierre Lepage; Karine Lavergne; Amelie Villeneuve; Tiffany Gaudin; Helena Brändström; Allon Beck; Andrei Verner; Jade Kingsley; Eef Harmsen; Damian Labuda; Kenneth Morgan; Marie-Claude Vohl; Anna K Naumova; Daniel Sinnett; Thomas J Hudson
Journal:  Physiol Genomics       Date:  2004-01-15       Impact factor: 3.107

4.  Transient neonatal cystinuria.

Authors:  Marylise Boutros; Caroline Vicanek; Rima Rozen; Paul Goodyer
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

Review 5.  Treatment of cystinuria.

Authors:  D Joly; P Rieu; A Méjean; M F Gagnadoux; M Daudon; P Jungers
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

6.  Identification of novel cystinuria mutations and polymorphisms in SLC3A1 and SLC7A9 genes: absence of SLC7A10 gene mutations in cystinuric patients.

Authors:  Anthoula Chatzikyriakidou; Nikolaos Sofikitis; Ioannis Georgiou
Journal:  Genet Test       Date:  2005

7.  Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss.

Authors:  Xue Zhong Liu; Xiao Mei Ouyang; Xia Juan Xia; Jing Zheng; Arti Pandya; Fang Li; Li Lin Du; Katherine O Welch; Christine Petit; Richard J H Smith; Bradley T Webb; Denise Yan; Kathleen S Arnos; David Corey; Peter Dallos; Walter E Nance; Zheng Yi Chen
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

Review 8.  The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction.

Authors:  Matthias A Hediger; Michael F Romero; Ji-Bin Peng; Andreas Rolfs; Hitomi Takanaga; Elspeth A Bruford
Journal:  Pflugers Arch       Date:  2003-11-18       Impact factor: 3.657

9.  Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-Type I cystinuria.

Authors:  M A Font; L Feliubadaló; X Estivill; V Nunes; E Golomb; Y Kreiss; E Pras; L Bisceglia; A P d'Adamo; L Zelante; P Gasparini; M T Bassi; A L George ; M Manzoni; M Riboni; A Ballabio; G Borsani; N Reig; E Fernández; A Zorzano; J Bertran; M Palacín
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

10.  Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification.

Authors:  Luca Dello Strologo; Elon Pras; Claudia Pontesilli; Ercole Beccia; Vittorino Ricci-Barbini; Luisa de Sanctis; Alberto Ponzone; Michele Gallucci; Luigi Bisceglia; Leopoldo Zelante; Maite Jimenez-Vidal; Mariona Font; Antonio Zorzano; Ferran Rousaud; Virginia Nunes; Paolo Gasparini; Manuel Palacín; Gianfranco Rizzoni
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

View more
  5 in total

1.  Clinical utility gene card for: Cystinuria.

Authors:  Thomas Eggermann; Klaus Zerres; Virginia Nunes; Mariona Font-Llitjós; Luigi Bisceglia; Anthoula Chatzikyriakidou; Luca dello Strologo; Elon Pras; John Creemers; Manuel Palacin
Journal:  Eur J Hum Genet       Date:  2011-08-24       Impact factor: 4.246

2.  Mutation analysis of SLC3A1 and SLC7A9 genes in patients with cystinuria.

Authors:  Leila Koulivand; Mehrdad Mohammadi; Behrouz Ezatpour; Rasoul Salehi; Samane Markazi; Sepideh Dashti; Majid Kheirollahi
Journal:  Urolithiasis       Date:  2015-06-30       Impact factor: 3.436

Review 3.  Pathophysiology and treatment of cystinuria.

Authors:  Josep Chillarón; Mariona Font-Llitjós; Joana Fort; Antonio Zorzano; David S Goldfarb; Virginia Nunes; Manuel Palacín
Journal:  Nat Rev Nephrol       Date:  2010-06-01       Impact factor: 28.314

Review 4.  Cystinuria-a urologist's perspective.

Authors:  Kay Thomas; Kathie Wong; John Withington; Matthew Bultitude; Angela Doherty
Journal:  Nat Rev Urol       Date:  2014-03-25       Impact factor: 14.432

Review 5.  Cystinuria: an inborn cause of urolithiasis.

Authors:  Thomas Eggermann; Andreas Venghaus; Klaus Zerres
Journal:  Orphanet J Rare Dis       Date:  2012-04-05       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.